{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:51:53Z","timestamp":1775238713063,"version":"3.50.1"},"reference-count":35,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3892\/ijo.2015.2962","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T08:58:57Z","timestamp":1428569937000},"page":"2562-2572","source":"Crossref","is-referenced-by-count":26,"title":["B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity"],"prefix":"10.3892","volume":"46","author":[{"given":"WEI","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YANFANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FEI","family":"DONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MINGXIA","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WENLI","family":"WAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAISHEN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FEIFEI","family":"WU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XINXING","family":"YAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOYAN","family":"KE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"key20180107184312_b1-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2014-05-521898","article-title":"Mantle cell lymphoma: Evolving management strategies","volume":"125","author":"Campo","year":"2015","journal-title":"Blood"},{"key":"key20180107184312_b2-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.13000","article-title":"Current regimens and novel agents for mantle cell lymphoma","volume":"167","author":"Chen","year":"2014","journal-title":"Br J Haematol"},{"key":"key20180107184312_b3-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2009-02-179739","article-title":"How I treat mantle cell lymphoma","volume":"114","author":"Ghielmini","year":"2009","journal-title":"Blood"},{"key":"key20180107184312_b4-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/85339","article-title":"B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production","volume":"2","author":"Chapoval","year":"2001","journal-title":"Nat Immunol"},{"key":"key20180107184312_b5-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.4049\/jimmunol.172.4.2352","article-title":"Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains","volume":"172","author":"Steinberger","year":"2004","journal-title":"J Immunol"},{"key":"key20180107184312_b6-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1158\/0008-5472.CAN-08-4517","article-title":"MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: Potential implications for immune based therapy of human solid tumors","volume":"69","author":"Xu","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107184312_b7-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yexcr.2012.09.006","article-title":"Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response","volume":"319","author":"Chen","year":"2013","journal-title":"Exp Cell Res"},{"key":"key20180107184312_b8-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/sj.bjc.6605375","article-title":"Clinical importance of B7-H3 expression in human pancreatic cancer","volume":"101","author":"Yamato","year":"2009","journal-title":"Br J Cancer"},{"key":"key20180107184312_b9-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/ijc.27566","article-title":"B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer","volume":"131","author":"Ingebrigtsen","year":"2012","journal-title":"Int J Cancer"},{"key":"key20180107184312_b10-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s00262-012-1278-5","article-title":"B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence","volume":"61","author":"Sun","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107184312_b11-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/SLA.0b013e3181f1939d","article-title":"B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis","volume":"252","author":"Arigami","year":"2010","journal-title":"Ann Surg"},{"key":"key20180107184312_b12-ijo-46-06-2562","article-title":"Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia","author":"Hu","year":"2014","journal-title":"Hematology"},{"key":"key20180107184312_b13-ijo-46-06-2562","first-page":"637","article-title":"Relation of B7-H3 molecule expression in multiple myeloma with poor prognosis and bone destruction","volume":"21","author":"Zhao","year":"2013","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"key20180107184312_b14-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-0609.2012.01766.x","article-title":"The B7 homologues and their receptors in hematologic malignancies","volume":"88","author":"Wilcox","year":"2012","journal-title":"Eur J Haematol"},{"key":"key20180107184312_b15-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.173.9.5445","article-title":"B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells","volume":"173","author":"Luo","year":"2004","journal-title":"J Immunol"},{"key":"key20180107184312_b16-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/sj.gt.3302070","article-title":"Mouse B7-H3 induces antitumor immunity","volume":"10","author":"Sun","year":"2003","journal-title":"Gene Ther"},{"key":"key20180107184312_b17-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2011.09.012","article-title":"Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis","volume":"124","author":"Brunner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180107184312_b18-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/eji.200839028","article-title":"B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction","volume":"39","author":"Leitner","year":"2009","journal-title":"Eur J Immunol"},{"key":"key20180107184312_b19-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ni967","article-title":"The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses","volume":"4","author":"Suh","year":"2003","journal-title":"Nat Immunol"},{"key":"key20180107184312_b20-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/ijc.26238","article-title":"B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes","volume":"130","author":"Tekle","year":"2012","journal-title":"Int J Cancer"},{"key":"key20180107184312_b21-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/156800908785133141","article-title":"The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion","volume":"8","author":"Chen","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107184312_b22-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1158\/1078-0432.CCR-11-0880","article-title":"Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness","volume":"18","author":"Lemke","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107184312_b23-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3892\/ijmm.2012.1212","article-title":"B7-H3 overexpression in pancreatic cancer promotes tumor progression","volume":"31","author":"Zhao","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20180107184312_b24-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.juro.2011.04.103","article-title":"B7-H3 over expression in prostate cancer promotes tumor cell progression","volume":"186","author":"Yuan","year":"2011","journal-title":"J Urol"},{"key":"key20180107184312_b25-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"e70689","DOI":"10.1371\/journal.pone.0070689","article-title":"B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"key20180107184312_b26-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/1535-7163.MCT-11-0072","article-title":"B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2\/Stat3 phosphorylation","volume":"10","author":"Liu","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20180107184312_b27-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3892\/ol.2013.1118","article-title":"Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma","volume":"5","author":"Zhao","year":"2013","journal-title":"Oncol Lett"},{"key":"key20180107184312_b28-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3109\/10428194.2012.673228","article-title":"Contribution of PD-L1 to oncogenesis of lymphoma and its RNAi-based targeting therapy","volume":"53","author":"Li","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"key20180107184312_b29-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: An open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"key":"key20180107184312_b30-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/jid.2013.114","article-title":"B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma","volume":"133","author":"Wang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"key20180107184312_b31-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","article-title":"B7-H3 and B7-H4 expression in non-small-cell lung cancer","volume":"53","author":"Sun","year":"2006","journal-title":"Lung Cancer"},{"key":"key20180107184312_b32-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0955-0674(98)80035-5","article-title":"Matrix metalloproteinase degradation of extracellular matrix: Biological consequences","volume":"10","author":"Shapiro","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107184312_b33-ijo-46-06-2562","article-title":"Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma","author":"Mussetti","year":"2014","journal-title":"Blood"},{"key":"key20180107184312_b34-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s12032-014-0944-1","article-title":"Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma","volume":"31","author":"Gil","year":"2014","journal-title":"Med Oncol"},{"key":"key20180107184312_b35-ijo-46-06-2562","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-12-0715","article-title":"Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity","volume":"18","author":"Loo","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.2962\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T01:34:12Z","timestamp":1566524052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.2962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,4,9]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.3892\/ijo.2015.2962"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.2962","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}